Author:
Bryant Andrew,Grayling Michael,Elattar Ahmed,Gajjar Ketankumar,Craig Dawn,Vale Luke,Naik Raj
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference40 articles.
1. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery;Bryant;Cochrane Database Syst Rev.,2021
2. Residual disease threshold after primary surgical treatment for advanced epithelial ovarian cancer (EOC): a network meta-analysis;Bryant;BMC Syst Rev.,2022
3. Ovarian cancer;Colombo;Crit Rev Oncol/Hematol,2006
4. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients;Vergote;Gynecol Oncol.,1998
5. Treatment of patients with early epithelial ovarian cancer;Vergote;Curr Opin Oncol.,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献